Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD

Y. Kashiwagi (Otsu, Japan)

Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Session: Classifying COPD with multidimensional scores and biomarkers
Session type: Thematic Poster
Number: 1111
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Kashiwagi (Otsu, Japan). Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD. 1111

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fractional exhaled nitric oxide in bronchiectasis
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Exhaled nitric oxide increases in chronic eosinophilic pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002

Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma
Source: Eur Respir J 2016; 48: 242-244
Year: 2016


An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007


Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Exhaled nitric oxide and COPD
Source: Eur Respir J 2010; 36: 692
Year: 2010



The use of exhaled nitric oxide concentration as a means of excluding eosinophilic inflammation in chronic cough
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009

Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003



Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004

Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Fractional exhaled nitric oxide (FeNO)
Source: Respipedia Article
Year: 2017

Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007